Midbrain dopaminergic neuron differentiation

pathway activity — cross-omics
GO:1904948Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Midbrain dopaminergic neuron differentiation pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ADAM12, SEC23A, and COL10A1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Midbrain dopaminergic neuron differentiation activity versus ADAM12 in LUAD (Pearson r = -0.12).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADADAM12 →+0.864+0.141.002.00135
PDACSEC23A →+0.347+0.211.002<.00135
COADCOL10A1 →+1.244+0.259.001<.00135
LSCCFRMD6 →+0.895+0.201<.001.00135
LUADGJA1 →+0.803+0.116<.001.00334
LSCCTLCD2 →+0.612+0.209<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1904948 vs ADAM12 — LUAD

Per-sample scatter of Midbrain dopaminergic neuron differentiation activity vs ADAM12 in LUAD.

Explore this scatter interactively →

Exploration